“adalimumab” Archives

in
Entry Author Date Location
Celgene to Sell Blockbuster Drug to Amgen for $13B to Close BMS Deal 08/26/19 New York
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away 02/26/19 National
Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive’s End 10/19/18 National
Eli Lilly’s Arthritis Drug Approved at Lower Dose with Boxed Warning 06/01/18 Indiana
Exact Sciences Brings on Mark Stenhouse as President of Cologuard 03/20/18 Wisconsin
Early Data for Celgene’s Oral Crohn’s Drug Gets Mixed Reaction 10/17/16 New York
Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More 10/07/16 National
Sofinnova, Atlas Put $35M Into Delinia to Tackle Autoimmune Diseases 09/14/16 Boston
In M&A Bonanza, AbbVie, Sanofi Throw Billions at Stemcentrx, Medivation 04/28/16 San Francisco
Synlogic Nabs $40M, Prepares To Put Modified Microbes Into Patients 02/17/16 Boston
Advancing Drugs at Roche, Sophiris, Coherus, and Other Bio News 11/13/15 San Diego
American Copycats: Can Biosimilars Catch On And Cut Costs In U.S.? 09/15/15 National
GSK Deepens Ties With Electro-Stim Startup SetPoint in $15M Funding 09/08/15 San Francisco
Drug Discovery in Seattle 2015: An Updated History 08/03/15 Seattle
East Coast Biotech Roundup: Regeneron, Synergy, Foundation & More 07/31/15 Boston
AbbVie Snaps up Pharmacyclics, Pays Whopping $21B For Cancer Drug 03/05/15 National
Déjà Vu For Gilman as New Immunology Startup, Padlock, Gets $23M 12/18/14 Boston
West Coast Biotech Roundup: Nevro, Coherus, Xenon, Rock Health, Etc. 11/06/14 San Francisco
Opsona, And Pharma Backers, Await Day of Reckoning for Kidney Drug 10/29/14 National
Bristol-Myers Kicks Arthritis Drug Back to Alder, Shares Tumble 09/02/14 Seattle
Celgene Gets FDA Nod For Oral Arthritis Drug 03/21/14 New York
Alder BioPharmaceuticals Hits IPO Trail Looking for $115M 03/19/14 Seattle
East Coast Biotech Roundup: Vertex, Dimension, Merrimack, & More 11/01/13 Boston
Oral Pill May Make Tough-to-Deliver RNAi Drugs Go Down Easy, RXi Says 11/13/08 Boston
Personalized Treatments for Cancer: Ensemble Moves Ahead with Roche on New Breed of Test 11/12/08 Boston
Illumina Shows its Stuff to Wall Street, Stock Still Slides 11/07/08 San Diego
Page 1 of 1